CrowdStrike Holdings, Inc. (CRWD) completed a 4-for-1 stock split on July 2, 2026, so many older targets must be read in split-adjusted terms. S&P Global's survey of 53 analysts puts the consensus average price target at $248.45, only modestly above the current quote, with a low of $132 and a high of $325. Because that overall average implies minimal upside, the $275 figure used here is calculated as the mean of the verified individual targets that remain above the current price. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Recent post-split actions show a generally constructive but measured Street view. Deutsche Bank upgraded the stock to Buy with a $300 target (November 2, 2026); Citi holds a $295 target; Bank of America carries a $290 target with a Hold rating; Mizuho maintains $275; KeyBanc holds $265; and Wedbush and Cantor Fitzgerald both stand at $250. Bulls cite platform consolidation and AI-driven security demand, while more cautious firms point to an elevated valuation that leaves limited room for execution missteps.
The stock closed at $244.68 on November 3, 2026, roughly 12.4% below the $275 target, a modest required move. CrowdStrike has already run substantially: shares touched a 52-week high of $286.99 in early October 2026 before pulling back, and the 52-week range spans $85.68 to $286.99. The company's market capitalization is about $250 billion.
Fundamentally, analysts model revenue rising from roughly $4.81 billion to $6.01 billion in fiscal 2026 (a gain near 25%) and to about $7.38 billion in fiscal 2027, with non-GAAP EPS (earnings per share) forecast to grow from about $0.93 to $1.26, then toward $1.61. That trajectory is solid, but the current P/E (price-to-earnings) ratio is exceptionally high because GAAP earnings remain thin, meaning the stock trades largely on growth expectations rather than current profitability. From what I see, this growth profile is what keeps many investors engaged despite the premium valuation.
Several verified factors could help the shares approach $275. Demand for AI-driven and agentic security continues to rise, and CrowdStrike has expanded its partnership with Nvidia (NVDA) to extend AI-agent security protections from software into silicon-level hardware. Channel checks have been constructive: Cantor Fitzgerald reported in August 2026 that 58% of surveyed partners were tracking ahead of plan, with ongoing endpoint share gains. Platform consolidation, where customers adopt multiple Falcon modules, supports durable ARR growth and improving margins. One thing that stands out is how the Nvidia collaboration could broaden the moat.
The principal obstacle is valuation. At roughly 12% above the current price, the target can be derailed if growth decelerates or software multiples compress across the sector. Competition in endpoint detection and response (EDR) and security operations remains intense, and the stock's premium pricing means even a modest miss on net new ARR could trigger de-rating. Insider activity has also leaned toward selling over recent quarters, which some investors read as a caution signal, though it is not a definitive indicator of business health. I’m watching this closely as any slowdown in ARR would stand out quickly.
The stock's recent pullback from the $286.99 high leaves that zone as a meaningful resistance area, with $275 sitting just below it. On the downside, the $240-to-$245 area near the current price is the first support level to watch, with the 60-day moving average and the psychologically important $200 level representing deeper support. The long-term trend remains upward following the post-split recovery, but the shares are below their early-October peak, indicating some consolidation.
Analyst price targets generally reflect a roughly 12-month outlook, though individual firms vary. The next major catalyst is the company's quarterly earnings report, expected around December 1, 2026, where net new ARR, revenue growth, guidance, and commentary on AI security adoption will matter most. Investors should also track analyst target revisions, cybersecurity sector momentum, and any shift in software valuations tied to interest-rate expectations.
In my research process, I find Tickeron’s AI Daily Buy/Sell Signals useful for spotting shifts in momentum across a wide range of names. These tools apply artificial intelligence to monitor thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and changing market conditions. They serve as a practical complement to fundamental work when evaluating opportunities like the one discussed here.
Can CRWD reach $275? The target, an average of analyst price targets above the current price, requires a modest move of roughly 12%. Supporting the case are strong revenue growth, rising AI-security demand, constructive channel checks, and fresh Buy ratings. Working against it are a demanding valuation, competitive pressure, insider selling, and a recent pullback from the 52-week high. The overall consensus mean of $248.45 and the wide $132-to-$325 range underscore genuine disagreement among analysts. The next earnings report and any analyst target revisions will be the most important near-term signposts, but no outcome is guaranteed.
When evaluating setups like this one, I often rely on Tickeron’s AI Daily Buy/Sell Signals to cross-check technical trends and generate systematic ideas. The platform scans a broad universe of securities and delivers actionable signals that can complement traditional research. It has become a regular part of my workflow for identifying potential entry or exit points without replacing core fundamental analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CRWD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 35 cases where CRWD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on CRWD as a result. In 70 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
CRWD moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRWD advanced for three days, in 287 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 250 of 317 cases where CRWD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The 10-day RSI Indicator for CRWD moved out of overbought territory on October 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 30 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 66 cases where CRWD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
The Moving Average Convergence Divergence Histogram (MACD) for CRWD turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 30 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRWD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 5 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. CRWD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (49.108) is normal, around the industry mean (16.526). CRWD's P/E Ratio (6524.800) is considerably higher than the industry average of (57.809). Projected Growth (PEG Ratio) (8.296) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.287) among similar stocks. P/S Ratio (45.662) is also within normal values, averaging (103.889).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company, which provides cloud-delivered solution for next-generation endpoint protection.
Industry ComputerCommunications